Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
RadNet has announced a new partnership with Santa Clara, California-based Whiterabbit.ai to improve mammography screening rates and breast cancer care through the use of AI and other advanced technologies.
Machine learning, natural language processing and social media can help researchers track the ongoing opioid epidemic, according to new findings published in JAMA Network Open.
Medical imaging service providers now can harness the power of artificial intelligence directly within their natural workflow by leveraging a new solution from Intelerad Medical Systems™, a leader in enterprise workflow solutions.
It is traditionally believed that men and women experience angina—the pain associated with coronary artery disease—in different ways, with men feeling it in their chest and women feeling it in their arms and back.
PathAI, a Boston-based healthcare technology company, has found that AI can help specialists quantify PD-L1 expression on both tumor cells and immune cells.
Cancer Research UK, one of the world’s largest charities focused on improving cancer treatments, has launched a new research network focused on advanced radiotherapy techniques, immunotherapies and AI.
Numerous healthcare providers and technology companies are working together on a new research project focused on using AI to improve care for patients with subarachnoid hemorrhages and diabetes.
